Positron emission tomography molecular imaging to monitor anti-tumor systemic response for immune checkpoint inhibitor therapy

Immune checkpoint inhibitors (ICIs) achieve a milestone in cancer treatment. Despite the great success of ICI, ICI therapy still faces a big challenge due to heterogeneity of tumor, and therapeutic response is complicated by possible immune-related adverse events (irAEs). Therefore, it is critical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Xiaoqing, Zhao, Qing, Zhou, Jinyun, Zhou, Rui, Liu, Yu, Qin, Xiyi, Zhang, Mingrong, Zhong, Yan, Wang, Jing, Tian, Mei, Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119238/
https://www.ncbi.nlm.nih.gov/pubmed/36622406
http://dx.doi.org/10.1007/s00259-022-06084-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119238/
https://www.ncbi.nlm.nih.gov/pubmed/36622406
http://dx.doi.org/10.1007/s00259-022-06084-1

Ejemplares similares